ID27128A - Proses pembuatan penghambat 5-lipoksigenase yang memiliki sistem-sistem cincin heterosiklus yang bervariasi - Google Patents

Proses pembuatan penghambat 5-lipoksigenase yang memiliki sistem-sistem cincin heterosiklus yang bervariasi

Info

Publication number
ID27128A
ID27128A IDP20000710A ID20000710A ID27128A ID 27128 A ID27128 A ID 27128A ID P20000710 A IDP20000710 A ID P20000710A ID 20000710 A ID20000710 A ID 20000710A ID 27128 A ID27128 A ID 27128A
Authority
ID
Indonesia
Prior art keywords
lipoxoxigene
heterosiclus
hazards
varied
making
Prior art date
Application number
IDP20000710A
Other languages
English (en)
Indonesian (id)
Inventor
Timothy Norris
Megan Elizabeth Hnatow
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID27128A publication Critical patent/ID27128A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IDP20000710A 1999-08-31 2000-08-28 Proses pembuatan penghambat 5-lipoksigenase yang memiliki sistem-sistem cincin heterosiklus yang bervariasi ID27128A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15161099P 1999-08-31 1999-08-31

Publications (1)

Publication Number Publication Date
ID27128A true ID27128A (id) 2001-03-01

Family

ID=22539510

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP20000710A ID27128A (id) 1999-08-31 2000-08-28 Proses pembuatan penghambat 5-lipoksigenase yang memiliki sistem-sistem cincin heterosiklus yang bervariasi

Country Status (33)

Country Link
EP (1) EP1081144A3 (cs)
JP (1) JP2001106686A (cs)
KR (1) KR20010050274A (cs)
CN (1) CN1286251A (cs)
AP (1) AP2000001909A0 (cs)
AR (1) AR022650A1 (cs)
AU (1) AU5370200A (cs)
BG (1) BG104730A (cs)
BR (1) BR0003888A (cs)
CA (1) CA2316748A1 (cs)
CO (1) CO5180623A1 (cs)
CZ (1) CZ20003159A3 (cs)
EA (1) EA200000803A3 (cs)
EE (1) EE200000513A (cs)
GT (1) GT200000144A (cs)
HR (1) HRP20000565A2 (cs)
HU (1) HUP0003437A3 (cs)
ID (1) ID27128A (cs)
IL (1) IL138089A0 (cs)
IS (1) IS5604A (cs)
MA (1) MA26750A1 (cs)
NO (1) NO20004312L (cs)
NZ (1) NZ506633A (cs)
OA (1) OA11451A (cs)
PA (1) PA8499601A1 (cs)
PE (1) PE20010523A1 (cs)
PL (1) PL342280A1 (cs)
SG (1) SG87145A1 (cs)
SK (1) SK12862000A3 (cs)
SV (1) SV2002000160A (cs)
TN (1) TNSN00176A1 (cs)
TR (1) TR200002530A2 (cs)
UY (1) UY26315A1 (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1627644A4 (en) * 2003-05-23 2012-01-18 Hisamitsu Pharmaceutical Co PREPARATION FOR EXTERNAL PERCUTANEOUS ADMINISTRATION WITH AN NON-TEROIDAL INFLAMMATORY MEDICAMENT AND AN INTERLEUKIN 1A PRODUCTION INHIBITOR
EP1834953A1 (en) * 2006-03-14 2007-09-19 Ranbaxy Laboratories Limited Tetrahydropyrane derivatives as 5-lipoxygenase inhibitors
CN103980312B (zh) * 2014-05-27 2016-09-07 广州大学 一种n杂环双膦配体及其合成方法
WO2025038927A1 (en) * 2023-08-16 2025-02-20 Raythera, Inc. Modulators of tnf alpha activity and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK281577B6 (sk) * 1994-10-18 2001-05-10 Pfizer Inc. Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze

Also Published As

Publication number Publication date
TNSN00176A1 (fr) 2005-11-10
UY26315A1 (es) 2001-04-30
PA8499601A1 (es) 2002-02-21
CO5180623A1 (es) 2002-07-30
SK12862000A3 (sk) 2002-02-05
BG104730A (en) 2001-09-28
EA200000803A2 (ru) 2001-04-23
HUP0003437A2 (hu) 2001-06-28
SG87145A1 (en) 2002-03-19
IS5604A (is) 2001-03-01
MA26750A1 (fr) 2004-12-20
AP2000001909A0 (en) 2000-09-30
JP2001106686A (ja) 2001-04-17
TR200002530A2 (tr) 2001-04-20
OA11451A (en) 2003-12-08
BR0003888A (pt) 2001-12-11
HRP20000565A2 (en) 2001-06-30
KR20010050274A (ko) 2001-06-15
CZ20003159A3 (cs) 2001-12-12
PL342280A1 (en) 2001-03-12
GT200000144A (es) 2002-02-20
AU5370200A (en) 2001-03-08
CA2316748A1 (en) 2001-02-28
HU0003437D0 (en) 2000-08-30
HUP0003437A3 (en) 2002-08-28
NO20004312D0 (no) 2000-08-30
SV2002000160A (es) 2002-01-23
PE20010523A1 (es) 2001-04-28
EE200000513A (et) 2001-04-16
EP1081144A3 (en) 2001-04-11
EA200000803A3 (ru) 2001-06-25
AR022650A1 (es) 2002-09-04
NO20004312L (no) 2001-03-01
IL138089A0 (en) 2001-10-31
NZ506633A (en) 2001-12-21
CN1286251A (zh) 2001-03-07
EP1081144A2 (en) 2001-03-07

Similar Documents

Publication Publication Date Title
PT1150966E (pt) Metodo de preparacao de 5-cianoftalido
ID22641A (id) Proses pembuatan e-kaprolaktam
ID27111A (id) Proses pembuatan epoksida
ID27494A (id) Proses pembuatan epoksida
ID25901A (id) Proses pembuatan 4-aminometil-pirolidin-3-on terlindung
ID26097A (id) Proses pembuatan pakaian luar sekali pakai
ID22877A (id) Proses pembuatan diena terkonjugasi yang dimurnikan
ID24971A (id) Proses baru pembuatan ketimin
EG22480A (en) Manufacture of centrifuged pipes
ID27128A (id) Proses pembuatan penghambat 5-lipoksigenase yang memiliki sistem-sistem cincin heterosiklus yang bervariasi
AU2001265935A1 (en) Production of biohydrolysates
EP1278817A4 (en) METHOD FOR PRODUCING A SILVER-CONTAINING CANDLE
EP1218407A4 (en) USES OF KAPPA-CONOTOXIN PVIIA
ID24733A (id) Proses pembuatan paroksetin hidroklorida
GB9924752D0 (en) Method of construction
ID30118A (id) Proses pembuatan turunan-turunan daeza-adenosin tersubstitusi-n6
ID25705A (id) Proses pembuatan 8-siklopentil-6-etil-3-[tersubstitusi]-5,8-dihidro-4h-1 3a 8-pentaaza-as-indasena dan senyawa-senyawa antaranya yang berguna
TW406777U (en) Structure of lighting set
GB9802487D0 (en) Production of heptafluoropane
TW467442U (en) Improved structure of wire-notch ring
TW437319U (en) Improved structure of ring
ID26061A (id) Proses pembuatan 2-fenil-3-aminopiridin, derivat-derivat fenilnya yang disubstitusi, dan garam-garamnya
TW402912U (en) Improvement of ring censer structure
EE200200053A (et) Isoretinoiini valmistamise protsess
TW493375U (en) Structure of connection ring